MARTINE ZIMMERMANN, PHARM.D.

Corporate Board Profile

Tech Score: 0/100

LIGAND PHARMACEUTICALS INC

Filing Date	Source Excerpt
2024-04-25	Martine Zimmermann, Pharm.D. (N) 55 2023 SVP, Head of Regulatory Affairs and R&D Quality at Ipsen Biopharmaceuticals ... (A) Member of the audit committee (the “Audit Committee”). (HC) Member of the human capital management and compensation committee (the “Human Capital Management and Compensation Committee”). (N) Member of the nominating and corporate governance committee (the “Nominating and Corporate Governance Committee”). ... DIRECTOR COMPENSATION TABLE ... Martine Zimmermann, PharmD. 37,511 134,998 295,363 467,872 ... The Nominating and Corporate Governance Committee currently consists of Mr. Aryeh (Chair), Ms. Zimmermann and Drs. Gray and Kozarich.

Filing Date

Source Excerpt

2024-04-25

Martine Zimmermann, Pharm.D. (N) 55 2023 SVP, Head of Regulatory Affairs and R&D Quality at Ipsen Biopharmaceuticals ... (A) Member of the audit committee (the “Audit Committee”). (HC) Member of the human capital management and compensation committee (the “Human Capital Management and Compensation Committee”). (N) Member of the nominating and corporate governance committee (the “Nominating and Corporate Governance Committee”). ... DIRECTOR COMPENSATION TABLE ... Martine Zimmermann, PharmD. 37,511 134,998 295,363 467,872 ... The Nominating and Corporate Governance Committee currently consists of Mr. Aryeh (Chair), Ms. Zimmermann and Drs. Gray and Kozarich.

Data sourced from SEC filings. Last updated: 2026-02-03